• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0702
Device Problem Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/14/2021
Event Type  malfunction  
Manufacturer Narrative
The device was returned.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report material separation it was reported that during preparation of the first steerable guide catheter (sgc 0106u119), the y-connector from the dilator became separated.Therefore, the sgc was not used in the patient.A second sgc (01009u125) was prepared for use.However, the sgc was not used in the patient due to anatomical challenges.The procedure was aborted.There was no patient involvement and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The returned device analysis confirmed the reported dilator rhv separation and concluded it was due to a sub-optimal bond.Based on the returned device investigation determined that the sub-optimal bond was likely related to the supplier process.As part of the supplier process, the proximal end of the dilator shaft is pressed onto the barbed luer fitting, which is threaded to the rotating hemostasis valve subassembly.The threaded junction is bonded together via a manual process where adhesive is applied and bonds the two parts together.Every dilator assembly is functionally tested by the supplier prior to shipment to abbott, including a leak test and hemostasis valve functional test which both verify that the rhv is intact prior to shipment to abbott.Upon receipt, abbott completes visual inspections and functional testing of every dilator, which consists of verifying that the rhv is intact, the cap on the rhv is able to rotate and a leak test.While no product nonconformance was identified, abbott is evaluating additional supplier controls to mitigate rhv separation due to a sub-optimal bond.A review of the manufacturing records for this event confirmed all inspections were within specification during production, the device associated with this complaint did not exhibit any abnormal results during the manufacturing process, and there were no non-conformances issued to the lot that would have contributed to the reported rhv separation.Additionally, a review of the complaint query identified no similar events from the lot.The reported event of a rhv separation and a sub-optimal bond are known foreseeable events with the mitraclip procedure.The calculated occurrence risk level is within the expected rate per the mitraclip risk assessment.Abbott will continue to track, and trend reported events of dilator rhv detachment issues.Na.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11282731
MDR Text Key231324040
Report Number2024168-2021-00893
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/15/2021
Device Catalogue NumberSGC0702
Device Lot Number01016U119
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2021
Initial Date Manufacturer Received 01/14/2021
Initial Date FDA Received02/04/2021
Supplement Dates Manufacturer Received05/26/2021
Supplement Dates FDA Received05/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-